Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer Robert T. Dauchy, Shulin Xiang, Lulu Mao, Samantha Brimer, Melissa A. Wren, Lin Yuan, Muralidharan Anbalagan, […]
Metastatic Male Breast Cancer: A Retrospective Cohort Analysis Robert Foerster, Lars Schroeder, Frank Foerster, Volker Wulff, Birgit Schubotz, Dieter Baaske, Christian Rudlowski Breast Care 2014; 9:267-271 Background This paper addresses an understudied area – how […]
I am very excited about this new prospective study of male breast cancer that was just announced. As the press release (below) states: “The second part of this Program, which is now open, is a […]
Piper Coutinho-Sledge, a grad student at the University of Chicago, recently contacted me about an interesting project that she is working on. Please see her call for participants below, and consider taking part. Her contact […]
Earlier this week I blogged about the cancer conference, the WIN Symposium which I attended last week. I summarized some of the current challenges in developing personalized cancer therapies, including the complexity of cancer. The […]
Last week I attended a great cancer conference, the WIN Symposium which this year was titled “Personalized Cancer Therapy – from Innovation to Implementation”. This conference has brought together some of the best thinkers and […]
In another month or so, I am joining an immunotherapy clinical trial that is aimed at suppressing recurrence, by training the immune system to pay attention to cancer cells more effectively. It is a trial designed […]
In a recent post I discussed the underfunding of basic research on the male form of breast cancer, and advocated for 1% of breast cancer research funding to involve male disease, in proportion to 1% […]
In a recent post, where I analyzed the relative underfunding of male breast cancer research, the issue of whether incidence and funding should be related came up. So I decided to take a look and […]
While there is nothing that forces a strict proportionality between cancer incidence and cancer research funding, there is something to be said for making sure that rare cancers are not left behind. Breast cancer in […]
Entering a World of Pink 